Showing results (341-350 of 408) with videos related to
Sort By:
Pageof 41
Ophthalmology. Retina|June 4, 2025
TALON Phase IIIb Study: 32-Week Primary Results of Brolucizumab Using Treat and Extend for Neovascular Age-Related Macular DegenerationCarl Regillo, Peter K Kaiser, Peter J Kertes, et al.Ophthalmology|April 17, 2016
Comprehensive Review of Ocular and Systemic Safety Events with Intravitreal Aflibercept Injection in Randomized Controlled TrialsJohn W Kitchens, Diana V Do, David S Boyer, et al.Ocular Immunology and Inflammation|September 3, 2025
Semi-Automated Analysis of Anterior Chamber Inflammation by Spectral-Domain Optical Coherence Tomography in Cataract Surgery PatientsNaveen Karthik, Sunil K Srivastava, Richard Gans, et al.Ophthalmology|October 3, 2007
Adverse events after intravitreal triamcinolone in patients with and without uveitisAnat Galor, Ron Margolis, Oswaldo M F Brasil, et al.Investigative Ophthalmology & Visual Science|March 11, 2008
Selective inhibition of angiogenesis in small blood vessels and decrease in vessel diameter throughout the vascular tree by triamcinolone acetonideTerri L McKay, Dan J Gedeon, Mary B Vickerman, et al.Ocular Immunology and Inflammation|May 21, 2010
Scleral thickness following fluocinolone acetonide implant (Retisert)Mehran Taban, Careen Y Lowder, Alexandre A C M Ventura, et al.Ophthalmology|November 24, 2024
Visual Loss in Geographic Atrophy: Learnings from the Lampalizumab TrialsNeha Anegondi, Verena Steffen, Srinivas R Sadda, et al.Eye (London, England)|January 12, 2022
Review of gene therapies for age-related macular degenerationArshad M Khanani, Mathew J Thomas, Aamir A Aziz, et al.Journal of Vitreoretinal Diseases|April 3, 2023
Diabetic Macular Edema Treated With Intravitreal Aflibercept Injection After Treatment With Other Anti-VEGF Agents (SWAP-TWO Study)-12-Month AnalysisCyrus Golshani, Thais F Conti, Felipe F Conti, et al.American Journal of Ophthalmology|June 13, 2008
Short-term outcomes of 23-gauge pars plana vitrectomyOmesh P Gupta, Allen C Ho, Peter K Kaiser, et al.Pageof 41